Pyrogen Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
Description
The global pyrogen testing market size is likely to be valued at US$ 2.5 Bn in 2025 and is estimated to reach US$ 5.3 Bn by 2032, growing at a CAGR of 11.33% during the forecast period 2025–2032. The market expansion is driven by rising demand for biologics, vaccines, and injectable therapeutics, coupled with stringent safety regulations from global regulatory authorities. Increasing product recalls due to contamination and heightened focus on advanced endotoxin and non-animal testing methods further fuel market growth.
Pyrogen Testing Market – Report Scope
The pyrogen testing market encompasses products, services, and technologies aimed at detecting fever-inducing contaminants in pharmaceuticals, biologics, and medical devices. These tests ensure patient safety and regulatory compliance by detecting endotoxins, microbial contaminants, and non-endotoxin pyrogens. The market is experiencing rapid adoption of in-vitro testing techniques such as recombinant Factor C assays and monocyte activation tests as alternatives to animal-based tests. Growing focus on advanced biologics, cell-based therapies, and implantable devices continues to strengthen the demand for reliable pyrogen testing solutions.
Market Growth Drivers
The growth of the global pyrogen testing market is strongly influenced by multiple factors. Increasing prevalence of biologics, vaccines, and biosimilars has led to higher requirements for contamination-free production. Stringent regulatory frameworks by agencies such as the FDA, EMA, and WHO emphasize rigorous safety checks, pushing manufacturers to adopt advanced pyrogen testing technologies. The ongoing shift from animal-based tests toward in-vitro methods reflects the industry’s commitment to ethical, efficient, and reliable testing practices. Additionally, the rise in contract research and manufacturing services further accelerates the demand for standardized and cost-effective pyrogen detection tools.
Market Restraints
Despite its promising outlook, the market faces several limitations. The high cost of advanced instruments and assays often acts as a barrier for smaller laboratories and manufacturers. Dependence on sophisticated equipment and skilled personnel further complicates widespread adoption. Regulatory differences across regions sometimes create challenges in test standardization. Moreover, traditional rabbit pyrogen tests, though less favored, still exist in some markets, delaying the universal adoption of novel in-vitro alternatives. Resistance to shifting from established methods to newer technologies also poses a restraint for faster market penetration.
Market Opportunities
Significant opportunities exist in this market as demand for biologics and next-generation therapies continues to expand globally. Rising interest in personalized medicine and cell and gene therapies necessitates more precise and reliable safety testing methods. The expansion of the pharmaceutical and biotechnology industries in emerging economies such as India, China, and Brazil offers new avenues for growth. Increasing investments in automated endotoxin testing systems, combined with partnerships between testing service providers and pharmaceutical companies, further enhance the opportunity landscape. Growing emphasis on non-animal testing methods also opens doors for innovation in ethical, sustainable, and faster testing solutions.
Regional Outlook
• North America dominates the pyrogen testing market due to strong pharmaceutical and biotechnology industries, coupled with strict regulatory oversight by the FDA.
• Europe follows closely, driven by early adoption of in-vitro testing alternatives, strong presence of key players, and robust clinical research activities.
• Asia Pacific is expected to witness the fastest growth, supported by expanding drug manufacturing capacity in countries like India, China, and South Korea, alongside favorable government initiatives.
• Latin America and the Middle East & Africa are emerging regions, where increasing investments in healthcare infrastructure and clinical research drive demand for standardized pyrogen testing.
Leading Companies
Leading companies in the global pyrogen testing market include:
• Thermo Fisher Scientific
• Merck KGaA
• Lonza
• MAT-BioTech
• Promega Corporation
• GenScript
• Associates of Cape Cod, Inc.
• BIOMERIEUX SA
• Ella A/S
• Hycult Biotech Inc.
• Eurofins Biolab Srl
• Solvias AG
• Wickham Laboratories Ltd.
• Sotera Health (Nelson Laboratories, LLC)
• Charles River Laboratories
• Creative Biolabs
• Sanquin Reagents B.V.
• Fujifilm Wako Pure Chemical Corporation
• MAT Research
• Xiamen Bioendo Technology Co. Ltd.
• Microcoat Biotechnologie GmbH
• PerkinElmer Inc.
• Orchid Scientific & Innovative Pvt Ltd.
Market Segmentation
By Product & Service:
• Instruments
Digital Tele Thermometers Equipment
Automated Endotoxin Testing Equipment
Portable Endotoxin Testing Equipment
Microplate Readers
• Test Kits & Reagents
Recombinant Factor C Assays
Limulus Amebocyte Lysate (LAL) Tests
Chromogenic Tests
Turbidimetric Tests
Gel-Clot Tests
Rabbit Pyrogen Tests
Monocyte Activity Assays
• Consumables
• Services
Endotoxin Testing Services
Monocyte Activation Testing Services
By Source:
• In-vitro-based Pyrogen Testing
Whole Blood-based Monocytes
Peripheral Blood Mononuclear Cell (PBMC)-based Monocytes
Cell Line-based Monocytes
• Animal-based Pyrogen Testing
Recombinant Factor (rFC)
Bacterial Endotoxins (BET)
Rabbit Pyrogen Tests
By Application:
• Injectable Therapeutics
• Vaccines
• Orally-dosed Pharmaceuticals
• Biologics
• Implantable Medical Devices
• Dialysis Liquids
• Toxic/Immune-modulatory Drugs
• Blood-based Products
By End User:
• Pharmaceutical Companies
• Biotechnology Companies
• Medical Device Companies
• Diagnostic Laboratories
• Clinical Research Organizations (CROs)
• Clinical Manufacturing Organizations (CMOs)
By Region:
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa
Please note: Delivery Timelines - 5 working days.
Pyrogen Testing Market – Report Scope
The pyrogen testing market encompasses products, services, and technologies aimed at detecting fever-inducing contaminants in pharmaceuticals, biologics, and medical devices. These tests ensure patient safety and regulatory compliance by detecting endotoxins, microbial contaminants, and non-endotoxin pyrogens. The market is experiencing rapid adoption of in-vitro testing techniques such as recombinant Factor C assays and monocyte activation tests as alternatives to animal-based tests. Growing focus on advanced biologics, cell-based therapies, and implantable devices continues to strengthen the demand for reliable pyrogen testing solutions.
Market Growth Drivers
The growth of the global pyrogen testing market is strongly influenced by multiple factors. Increasing prevalence of biologics, vaccines, and biosimilars has led to higher requirements for contamination-free production. Stringent regulatory frameworks by agencies such as the FDA, EMA, and WHO emphasize rigorous safety checks, pushing manufacturers to adopt advanced pyrogen testing technologies. The ongoing shift from animal-based tests toward in-vitro methods reflects the industry’s commitment to ethical, efficient, and reliable testing practices. Additionally, the rise in contract research and manufacturing services further accelerates the demand for standardized and cost-effective pyrogen detection tools.
Market Restraints
Despite its promising outlook, the market faces several limitations. The high cost of advanced instruments and assays often acts as a barrier for smaller laboratories and manufacturers. Dependence on sophisticated equipment and skilled personnel further complicates widespread adoption. Regulatory differences across regions sometimes create challenges in test standardization. Moreover, traditional rabbit pyrogen tests, though less favored, still exist in some markets, delaying the universal adoption of novel in-vitro alternatives. Resistance to shifting from established methods to newer technologies also poses a restraint for faster market penetration.
Market Opportunities
Significant opportunities exist in this market as demand for biologics and next-generation therapies continues to expand globally. Rising interest in personalized medicine and cell and gene therapies necessitates more precise and reliable safety testing methods. The expansion of the pharmaceutical and biotechnology industries in emerging economies such as India, China, and Brazil offers new avenues for growth. Increasing investments in automated endotoxin testing systems, combined with partnerships between testing service providers and pharmaceutical companies, further enhance the opportunity landscape. Growing emphasis on non-animal testing methods also opens doors for innovation in ethical, sustainable, and faster testing solutions.
Regional Outlook
• North America dominates the pyrogen testing market due to strong pharmaceutical and biotechnology industries, coupled with strict regulatory oversight by the FDA.
• Europe follows closely, driven by early adoption of in-vitro testing alternatives, strong presence of key players, and robust clinical research activities.
• Asia Pacific is expected to witness the fastest growth, supported by expanding drug manufacturing capacity in countries like India, China, and South Korea, alongside favorable government initiatives.
• Latin America and the Middle East & Africa are emerging regions, where increasing investments in healthcare infrastructure and clinical research drive demand for standardized pyrogen testing.
Leading Companies
Leading companies in the global pyrogen testing market include:
• Thermo Fisher Scientific
• Merck KGaA
• Lonza
• MAT-BioTech
• Promega Corporation
• GenScript
• Associates of Cape Cod, Inc.
• BIOMERIEUX SA
• Ella A/S
• Hycult Biotech Inc.
• Eurofins Biolab Srl
• Solvias AG
• Wickham Laboratories Ltd.
• Sotera Health (Nelson Laboratories, LLC)
• Charles River Laboratories
• Creative Biolabs
• Sanquin Reagents B.V.
• Fujifilm Wako Pure Chemical Corporation
• MAT Research
• Xiamen Bioendo Technology Co. Ltd.
• Microcoat Biotechnologie GmbH
• PerkinElmer Inc.
• Orchid Scientific & Innovative Pvt Ltd.
Market Segmentation
By Product & Service:
• Instruments
Digital Tele Thermometers Equipment
Automated Endotoxin Testing Equipment
Portable Endotoxin Testing Equipment
Microplate Readers
• Test Kits & Reagents
Recombinant Factor C Assays
Limulus Amebocyte Lysate (LAL) Tests
Chromogenic Tests
Turbidimetric Tests
Gel-Clot Tests
Rabbit Pyrogen Tests
Monocyte Activity Assays
• Consumables
• Services
Endotoxin Testing Services
Monocyte Activation Testing Services
By Source:
• In-vitro-based Pyrogen Testing
Whole Blood-based Monocytes
Peripheral Blood Mononuclear Cell (PBMC)-based Monocytes
Cell Line-based Monocytes
• Animal-based Pyrogen Testing
Recombinant Factor (rFC)
Bacterial Endotoxins (BET)
Rabbit Pyrogen Tests
By Application:
• Injectable Therapeutics
• Vaccines
• Orally-dosed Pharmaceuticals
• Biologics
• Implantable Medical Devices
• Dialysis Liquids
• Toxic/Immune-modulatory Drugs
• Blood-based Products
By End User:
• Pharmaceutical Companies
• Biotechnology Companies
• Medical Device Companies
• Diagnostic Laboratories
• Clinical Research Organizations (CROs)
• Clinical Manufacturing Organizations (CMOs)
By Region:
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa
Please note: Delivery Timelines - 5 working days.
Table of Contents
210 Pages
- 1. Executive Summary
- 1.1. Global Pyrogen Testing Market Snapshot
- 1.2. Future Projections
- 1.3. Key Market Trends
- 1.4. Regional Snapshot, by Value and Volume, 2024
- 1.5. Analyst Recommendations
- 2. Market Overview
- 2.1. Market Definitions and Segmentations
- 2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
- 2.3. Value Chain Analysis
- 2.4. Porter’s Five Forces Analysis
- 2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
- 2.6. Impact of Ukraine-Russia Conflict
- 2.7. Economic Overview
- 2.7.1. World Economic Projections
- 2.8. PESTLE Analysis
- 3. Production Output and Trade Statistics, 2019-2024
- 3.1. Global Pyrogen Testing Market Production Output, by Region, Value (US$ Bn) and Volume (Million Units), 2019-2024
- 3.1.1. North America
- 3.1.2. Europe
- 3.1.3. Asia Pacific
- 3.1.4. Latin America
- 3.1.5. Middle East and Africa
- 4. Price Analysis, 2019-2024
- 4.1. Global Average Price Analysis, by Product and Services/ Material, US$ Per Unit, 2019-2024
- 4.2. Prominent Factor Affecting Pyrogen Testing Market Prices
- 4.3. Global Average Price Analysis, by Region, US$ Per Unit
- 5. Global Pyrogen Testing Market Outlook, 2019-2032
- 5.1. Global Pyrogen Testing Market Outlook, by Product and Services, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 5.1.1. Key Highlights
- 5.1.1.1. Instruments
- 5.1.1.1.1. Digital Tele Thermometers Equipment
- 5.1.1.1.2. Automated Endotoxin Testing Equipment
- 5.1.1.1.3. Portable Endotoxin Testing Equipment
- 5.1.1.1.4. Microplate Readers
- 5.1.1.2. Test Kits & Reagents
- 5.1.1.2.1. Recombinant Factor C Assays
- 5.1.1.2.2. Limulus Amebocyte Lysate (LAL) Tests
- 5.1.1.2.2.1. Chromogenic Tests
- 5.1.1.2.2.2. Turbid metric Tests
- 5.1.1.2.2.3. Gel-Clot Tests
- 5.1.1.2.3. Rabbit Pyrogen Tests
- 5.1.1.2.4. Monocyte Activity Assays
- 5.1.1.3. Consumables
- 5.1.1.4. Services
- 5.1.1.4.1. Endotoxin Testing Services
- 5.1.1.4.2. Monocyte Activation Testing Services
- 5.2. Global Pyrogen Testing Market Outlook, by Source, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 5.2.1. Key Highlights
- 5.2.1.1. In-vitro-based Pyrogen Testing
- 5.2.1.1.1. Whole Blood-based Monocytes
- 5.2.1.1.2. Peripheral Blood Mononuclear Cell (PBMC)-based Monocytes
- 5.2.1.1.3. Cell Line-based Monocytes
- 5.2.1.2. Animal-based Pyrogen Testing
- 5.2.1.2.1. Recombinant Factor (rFC )
- 5.2.1.2.2. Bacterial Endotoxins (BET)
- 5.2.1.2.3. Rabbit Pyrogen Tests
- 5.3. Global Pyrogen Testing Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 5.3.1. Key Highlights
- 5.3.1.1. Injectable Therapeutics
- 5.3.1.2. Vaccines
- 5.3.1.3. Orally-dosed Pharmaceuticals
- 5.3.1.4. Biologics
- 5.3.1.5. Implantable Medical Devices
- 5.3.1.6. Dialysis Liquids
- 5.3.1.7. Toxic/immune-modulatory Drugs
- 5.3.1.8. Blood-based Products
- 5.4. Global Pyrogen Testing Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 5.4.1. Key Highlights
- 5.4.1.1. Pharmaceuticals Companies
- 5.4.1.2. Biotechnology Companies
- 5.4.1.3. Medical Device Companies
- 5.4.1.4. Diagnostic Laboratories
- 5.4.1.5. Clinical Research Organizations (CROs)
- 5.4.1.6. Clinical Manufacturing Organizations (CMOs)
- 5.5. Global Pyrogen Testing Market Outlook, by Region, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 5.5.1. Key Highlights
- 5.5.1.1. North America
- 5.5.1.2. Europe
- 5.5.1.3. Asia Pacific
- 5.5.1.4. Latin America
- 5.5.1.5. Middle East & Africa
- 6. North America Pyrogen Testing Market Outlook, 2019-2032
- 6.1. North America Pyrogen Testing Market Outlook, by Product and Services, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 6.1.1. Key Highlights
- 6.1.1.1. Instruments
- 6.1.1.1.1. Digital Tele Thermometers Equipment
- 6.1.1.1.2. Automated Endotoxin Testing Equipment
- 6.1.1.1.3. Portable Endotoxin Testing Equipment
- 6.1.1.1.4. Microplate Readers
- 6.1.1.2. Test Kits & Reagents
- 6.1.1.2.1. Recombinant Factor C Assays
- 6.1.1.2.2. Limulus Amebocyte Lysate (LAL) Tests
- 6.1.1.2.2.1. Chromogenic Tests
- 6.1.1.2.2.2. Turbid metric Tests
- 6.1.1.2.2.3. Gel-Clot Tests
- 6.1.1.2.3. Rabbit Pyrogen Tests
- 6.1.1.2.4. Monocyte Activity Assays
- 6.1.1.3. Consumables
- 6.1.1.4. Services
- 6.1.1.4.1. Endotoxin Testing Services
- 6.1.1.4.2. Monocyte Activation Testing Services
- 6.2. North America Pyrogen Testing Market Outlook, by Source, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 6.2.1. Key Highlights
- 6.2.1.1. In-vitro-based Pyrogen Testing
- 6.2.1.1.1. Whole Blood-based Monocytes
- 6.2.1.1.2. Peripheral Blood Mononuclear Cell (PBMC)-based Monocytes
- 6.2.1.1.3. Cell Line-based Monocytes
- 6.2.1.2. Animal-based Pyrogen Testing
- 6.2.1.2.1. Recombinant Factor (rFC )
- 6.2.1.2.2. Bacterial Endotoxins (BET)
- 6.2.1.2.3. Rabbit Pyrogen Tests
- 6.3. North America Pyrogen Testing Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 6.3.1. Key Highlights
- 6.3.1.1. Injectable Therapeutics
- 6.3.1.2. Vaccines
- 6.3.1.3. Orally-dosed Pharmaceuticals
- 6.3.1.4. Biologics
- 6.3.1.5. Implantable Medical Devices
- 6.3.1.6. Dialysis Liquids
- 6.3.1.7. Toxic/immune-modulatory Drugs
- 6.3.1.8. Blood-based Products
- 6.4. North America Pyrogen Testing Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 6.4.1. Key Highlights
- 6.4.1.1. Pharmaceuticals Companies
- 6.4.1.2. Biotechnology Companies
- 6.4.1.3. Medical Device Companies
- 6.4.1.4. Diagnostic Laboratories
- 6.4.1.5. Clinical Research Organizations (CROs)
- 6.4.1.6. Clinical Manufacturing Organizations (CMOs)
- 6.5. North America Pyrogen Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 6.5.1. Key Highlights
- 6.5.1.1. U.S. Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 6.5.1.2. U.S. Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 6.5.1.3. U.S. Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 6.5.1.4. U.S. Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 6.5.1.5. Canada Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 6.5.1.6. Canada Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 6.5.1.7. Canada Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 6.5.1.8. Canada Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 6.5.2. BPS Analysis/Market Attractiveness Analysis
- 7. Europe Pyrogen Testing Market Outlook, 2019-2032
- 7.1. Europe Pyrogen Testing Market Outlook, by Product and Services, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 7.1.1. Key Highlights
- 7.1.1.1. Instruments
- 7.1.1.1.1. Digital Tele Thermometers Equipment
- 7.1.1.1.2. Automated Endotoxin Testing Equipment
- 7.1.1.1.3. Portable Endotoxin Testing Equipment
- 7.1.1.1.4. Microplate Readers
- 7.1.1.2. Test Kits & Reagents
- 7.1.1.2.1. Recombinant Factor C Assays
- 7.1.1.2.2. Limulus Amebocyte Lysate (LAL) Tests
- 7.1.1.2.2.1. Chromogenic Tests
- 7.1.1.2.2.2. Turbid metric Tests
- 7.1.1.2.2.3. Gel-Clot Tests
- 7.1.1.2.3. Rabbit Pyrogen Tests
- 7.1.1.2.4. Monocyte Activity Assays
- 7.1.1.3. Consumables
- 7.1.1.4. Services
- 7.1.1.4.1. Endotoxin Testing Services
- 7.1.1.4.2. Monocyte Activation Testing Services
- 7.2. Europe Pyrogen Testing Market Outlook, by Source, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 7.2.1. Key Highlights
- 7.2.1.1. In-vitro-based Pyrogen Testing
- 7.2.1.1.1. Whole Blood-based Monocytes
- 7.2.1.1.2. Peripheral Blood Mononuclear Cell (PBMC)-based Monocytes
- 7.2.1.1.3. Cell Line-based Monocytes
- 7.2.1.2. Animal-based Pyrogen Testing
- 7.2.1.2.1. Recombinant Factor (rFC )
- 7.2.1.2.2. Bacterial Endotoxins (BET)
- 7.2.1.2.3. Rabbit Pyrogen Tests
- 7.3. Europe Pyrogen Testing Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 7.3.1. Key Highlights
- 7.3.1.1. Injectable Therapeutics
- 7.3.1.2. Vaccines
- 7.3.1.3. Orally-dosed Pharmaceuticals
- 7.3.1.4. Biologics
- 7.3.1.5. Implantable Medical Devices
- 7.3.1.6. Dialysis Liquids
- 7.3.1.7. Toxic/immune-modulatory Drugs
- 7.3.1.8. Blood-based Products
- 7.4. Europe Pyrogen Testing Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 7.4.1.1. Pharmaceuticals Companies
- 7.4.1.2. Biotechnology Companies
- 7.4.1.3. Medical Device Companies
- 7.4.1.4. Diagnostic Laboratories
- 7.4.1.5. Clinical Research Organizations (CROs)
- 7.4.1.6. Clinical Manufacturing Organizations (CMOs)
- 7.5. Europe Pyrogen Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 7.5.1. Key Highlights
- 7.5.1.1. Germany Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 7.5.1.2. Germany Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 7.5.1.3. Germany Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 7.5.1.4. Germany Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 7.5.1.5. U.K. Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 7.5.1.6. U.K. Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 7.5.1.7. U.K. Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 7.5.1.8. U.K. Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 7.5.1.9. France Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 7.5.1.10. France Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 7.5.1.11. France Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 7.5.1.12. France Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 7.5.1.13. Italy Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 7.5.1.14. Italy Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 7.5.1.15. Italy Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 7.5.1.16. Italy Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 7.5.1.17. Turkey Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 7.5.1.18. Turkey Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 7.5.1.19. Turkey Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 7.5.1.20. Turkey Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 7.5.1.21. Russia Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 7.5.1.22. Russia Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 7.5.1.23. Russia Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 7.5.1.24. Russia Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 7.5.1.25. Rest of Europe Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 7.5.1.26. Rest of Europe Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 7.5.1.27. Rest of Europe Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 7.5.1.28. Rest of Europe Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 7.5.2. BPS Analysis/Market Attractiveness Analysis
- 8. Asia Pacific Pyrogen Testing Market Outlook, 2019-2032
- 8.1. Asia Pacific Pyrogen Testing Market Outlook, by Product and Services, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 8.1.1. Key Highlights
- 8.1.1.1. Instruments
- 8.1.1.1.1. Digital Tele Thermometers Equipment
- 8.1.1.1.2. Automated Endotoxin Testing Equipment
- 8.1.1.1.3. Portable Endotoxin Testing Equipment
- 8.1.1.1.4. Microplate Readers
- 8.1.1.2. Test Kits & Reagents
- 8.1.1.2.1. Recombinant Factor C Assays
- 8.1.1.2.2. Limulus Amebocyte Lysate (LAL) Tests
- 8.1.1.2.2.1. Chromogenic Tests
- 8.1.1.2.2.2. Turbid metric Tests
- 8.1.1.2.2.3. Gel-Clot Tests
- 8.1.1.2.3. Rabbit Pyrogen Tests
- 8.1.1.2.4. Monocyte Activity Assays
- 8.1.1.3. Consumables
- 8.1.1.4. Services
- 8.1.1.4.1. Endotoxin Testing Services
- 8.1.1.4.2. Monocyte Activation Testing Services
- 8.2. Asia Pacific Pyrogen Testing Market Outlook, by Source, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 8.2.1. Key Highlights
- 8.2.1.1. In-vitro-based Pyrogen Testing
- 8.2.1.1.1. Whole Blood-based Monocytes
- 8.2.1.1.2. Peripheral Blood Mononuclear Cell (PBMC)-based Monocytes
- 8.2.1.1.3. Cell Line-based Monocytes
- 8.2.1.2. Animal-based Pyrogen Testing
- 8.2.1.2.1. Recombinant Factor (rFC )
- 8.2.1.2.2. Bacterial Endotoxins (BET)
- 8.2.1.2.3. Rabbit Pyrogen Tests
- 8.3. Asia Pacific Pyrogen Testing Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 8.3.1. Key Highlights
- 8.3.1.1. Injectable Therapeutics
- 8.3.1.2. Vaccines
- 8.3.1.3. Orally-dosed Pharmaceuticals
- 8.3.1.4. Biologics
- 8.3.1.5. Implantable Medical Devices
- 8.3.1.6. Dialysis Liquids
- 8.3.1.7. Toxic/immune-modulatory Drugs
- 8.3.1.8. Blood-based Products
- 8.4. Asia Pacific Pyrogen Testing Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 8.4.1. Key Highlights
- 8.4.1.1. Pharmaceuticals Companies
- 8.4.1.2. Biotechnology Companies
- 8.4.1.3. Medical Device Companies
- 8.4.1.4. Diagnostic Laboratories
- 8.4.1.5. Clinical Research Organizations (CROs)
- 8.4.1.6. Clinical Manufacturing Organizations (CMOs)
- 8.5. Asia Pacific Pyrogen Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 8.5.1. Key Highlights
- 8.5.1.1. China Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 8.5.1.2. China Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 8.5.1.3. China Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 8.5.1.4. China Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 8.5.1.5. Japan Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 8.5.1.6. Japan Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 8.5.1.7. Japan Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 8.5.1.8. Japan Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 8.5.1.9. South Korea Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 8.5.1.10. South Korea Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 8.5.1.11. South Korea Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 8.5.1.12. South Korea Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 8.5.1.13. India Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 8.5.1.14. India Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 8.5.1.15. India Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 8.5.1.16. India Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 8.5.1.17. Southeast Asia Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 8.5.1.18. Southeast Asia Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 8.5.1.19. Southeast Asia Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 8.5.1.20. Southeast Asia Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 8.5.1.21. Rest of Asia Pacific Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 8.5.1.22. Rest of Asia Pacific Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 8.5.1.23. Rest of Asia Pacific Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 8.5.1.24. Rest of Asia Pacific Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 8.5.2. BPS Analysis/Market Attractiveness Analysis
- 9. Latin America Pyrogen Testing Market Outlook, 2019-2032
- 9.1. Latin America Pyrogen Testing Market Outlook, by Product and Services, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 9.1.1. Key Highlights
- 9.1.1.1. Instruments
- 9.1.1.1.1. Digital Tele Thermometers Equipment
- 9.1.1.1.2. Automated Endotoxin Testing Equipment
- 9.1.1.1.3. Portable Endotoxin Testing Equipment
- 9.1.1.1.4. Microplate Readers
- 9.1.1.2. Test Kits & Reagents
- 9.1.1.2.1. Recombinant Factor C Assays
- 9.1.1.2.2. Limulus Amebocyte Lysate (LAL) Tests
- 9.1.1.2.2.1. Chromogenic Tests
- 9.1.1.2.2.2. Turbid metric Tests
- 9.1.1.2.2.3. Gel-Clot Tests
- 9.1.1.2.3. Rabbit Pyrogen Tests
- 9.1.1.2.4. Monocyte Activity Assays
- 9.1.1.3. Consumables
- 9.1.1.4. Services
- 9.1.1.4.1. Endotoxin Testing Services
- 9.1.1.4.2. Monocyte Activation Testing Services
- 9.2. Latin America Pyrogen Testing Market Outlook, by Source, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 9.2.1.1. In-vitro-based Pyrogen Testing
- 9.2.1.1.1. Whole Blood-based Monocytes
- 9.2.1.1.2. Peripheral Blood Mononuclear Cell (PBMC)-based Monocytes
- 9.2.1.1.3. Cell Line-based Monocytes
- 9.2.1.2. Animal-based Pyrogen Testing
- 9.2.1.2.1. Recombinant Factor (rFC )
- 9.2.1.2.2. Bacterial Endotoxins (BET)
- 9.2.1.2.3. Rabbit Pyrogen Tests
- 9.3. Latin America Pyrogen Testing Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 9.3.1. Key Highlights
- 9.3.1.1. Injectable Therapeutics
- 9.3.1.2. Vaccines
- 9.3.1.3. Orally-dosed Pharmaceuticals
- 9.3.1.4. Biologics
- 9.3.1.5. Implantable Medical Devices
- 9.3.1.6. Dialysis Liquids
- 9.3.1.7. Toxic/immune-modulatory Drugs
- 9.3.1.8. Blood-based Products
- 9.4. Latin America Pyrogen Testing Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 9.4.1. Key Highlights
- 9.4.1.1. Pharmaceuticals Companies
- 9.4.1.2. Biotechnology Companies
- 9.4.1.3. Medical Device Companies
- 9.4.1.4. Diagnostic Laboratories
- 9.4.1.5. Clinical Research Organizations (CROs)
- 9.4.1.6. Clinical Manufacturing Organizations (CMOs)
- 9.5. Latin America Pyrogen Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 9.5.1. Key Highlights
- 9.5.1.1. Brazil Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 9.5.1.2. Brazil Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 9.5.1.3. Brazil Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 9.5.1.4. Brazil Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 9.5.1.5. Mexico Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 9.5.1.6. Mexico Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 9.5.1.7. Mexico Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 9.5.1.8. Mexico Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 9.5.1.9. Argentina Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 9.5.1.10. Argentina Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 9.5.1.11. Argentina Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 9.5.1.12. Argentina Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 9.5.1.13. Rest of Latin America Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 9.5.1.14. Rest of Latin America Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 9.5.1.15. Rest of Latin America Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 9.5.1.16. Rest of Latin America Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 9.5.2. BPS Analysis/Market Attractiveness Analysis
- 10. Middle East & Africa Pyrogen Testing Market Outlook, 2019-2032
- 10.1. Middle East & Africa Pyrogen Testing Market Outlook, by Product and Services, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 10.1.1. Key Highlights
- 10.1.1.1. Instruments
- 10.1.1.1.1. Digital Tele Thermometers Equipment
- 10.1.1.1.2. Automated Endotoxin Testing Equipment
- 10.1.1.1.3. Portable Endotoxin Testing Equipment
- 10.1.1.1.4. Microplate Readers
- 10.1.1.2. Test Kits & Reagents
- 10.1.1.2.1. Recombinant Factor C Assays
- 10.1.1.2.2. Limulus Amebocyte Lysate (LAL) Tests
- 10.1.1.2.2.1. Chromogenic Tests
- 10.1.1.2.2.2. Turbid metric Tests
- 10.1.1.2.2.3. Gel-Clot Tests
- 10.1.1.2.3. Rabbit Pyrogen Tests
- 10.1.1.2.4. Monocyte Activity Assays
- 10.1.1.3. Consumables
- 10.1.1.4. Services
- 10.1.1.4.1. Endotoxin Testing Services
- 10.1.1.4.2. Monocyte Activation Testing Services
- 10.2. Middle East & Africa Pyrogen Testing Market Outlook, by Source, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 10.2.1. Key Highlights
- 10.2.1.1. In-vitro-based Pyrogen Testing
- 10.2.1.1.1. Whole Blood-based Monocytes
- 10.2.1.1.2. Peripheral Blood Mononuclear Cell (PBMC)-based Monocytes
- 10.2.1.1.3. Cell Line-based Monocytes
- 10.2.1.2. Animal-based Pyrogen Testing
- 10.2.1.2.1. Recombinant Factor (rFC )
- 10.2.1.2.2. Bacterial Endotoxins (BET)
- 10.2.1.2.3. Rabbit Pyrogen Tests
- 10.3. Middle East & Africa Pyrogen Testing Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 10.3.1. Key Highlights
- 10.3.1.1. Injectable Therapeutics
- 10.3.1.2. Vaccines
- 10.3.1.3. Orally-dosed Pharmaceuticals
- 10.3.1.4. Biologics
- 10.3.1.5. Implantable Medical Devices
- 10.3.1.6. Dialysis Liquids
- 10.3.1.7. Toxic/immune-modulatory Drugs
- 10.3.1.8. Blood-based Products
- 10.4. Middle East & Africa Pyrogen Testing Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 10.4.1. Key Highlights
- 10.4.1.1. Pharmaceuticals Companies
- 10.4.1.2. Biotechnology Companies
- 10.4.1.3. Medical Device Companies
- 10.4.1.4. Diagnostic Laboratories
- 10.4.1.5. Clinical Research Organizations (CROs)
- 10.4.1.6. Clinical Manufacturing Organizations (CMOs)
- 10.5. Middle East & Africa Pyrogen Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 10.5.1. Key Highlights
- 10.5.1.1. GCC Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 10.5.1.2. GCC Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 10.5.1.3. GCC Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 10.5.1.4. GCC Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 10.5.1.5. South Africa Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 10.5.1.6. South Africa Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 10.5.1.7. South Africa Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 10.5.1.8. South Africa Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 10.5.1.9. Egypt Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 10.5.1.10. Egypt Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 10.5.1.11. Egypt Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 10.5.1.12. Egypt Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 10.5.1.13. Nigeria Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 10.5.1.14. Nigeria Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 10.5.1.15. Nigeria Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 10.5.1.16. Nigeria Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 10.5.1.17. Rest of Middle East & Africa Pyrogen Testing Market by Product and Services, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 10.5.1.18. Rest of Middle East & Africa Pyrogen Testing Market by Source, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 10.5.1.19. Rest of Middle East & Africa Pyrogen Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 10.5.1.20. Rest of Middle East & Africa Pyrogen Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2019-2032
- 10.5.2. BPS Analysis/Market Attractiveness Analysis
- 11. Competitive Landscape
- 11.1. Product vs Indication Heatmap
- 11.2. Company Market Share Analysis, 2024
- 11.3. Competitive Dashboard
- 11.4. Company Profiles
- 11.4.1. Thermo Fisher Scientific
- 11.4.1.1. Company Overview
- 11.4.1.2. Product Portfolio
- 11.4.1.3. Financial Overview
- 11.4.1.4. Business Strategies and Development
- 11.4.2. Merck KgaA
- 11.4.2.1. Company Overview
- 11.4.2.2. Product Portfolio
- 11.4.2.3. Financial Overview
- 11.4.2.4. Business Strategies and Development
- 11.4.3. LONZA
- 11.4.3.1. Company Overview
- 11.4.3.2. Product Portfolio
- 11.4.3.3. Financial Overview
- 11.4.3.4. Business Strategies and Development
- 11.4.4. MAT- BioTech
- 11.4.4.1. Company Overview
- 11.4.4.2. Product Portfolio
- 11.4.4.3. Financial Overview
- 11.4.4.4. Business Strategies and Development
- 11.4.5. Promega Corporation
- 11.4.5.1. Company Overview
- 11.4.5.2. Product Portfolio
- 11.4.5.3. Financial Overview
- 11.4.5.4. Business Strategies and Development
- 11.4.6. GenScript
- 11.4.6.1. Company Overview
- 11.4.6.2. Product Portfolio
- 11.4.6.3. Financial Overview
- 11.4.6.4. Business Strategies and Development
- 11.4.7. ASSOCIATES OF CAPE COD, INC.,
- 11.4.7.1. Company Overview
- 11.4.7.2. Product Portfolio
- 11.4.7.3. Financial Overview
- 11.4.7.4. Business Strategies and Development
- 11.4.8. BioMérieux SA
- 11.4.8.1. Company Overview
- 11.4.8.2. Product Portfolio
- 11.4.8.3. Financial Overview
- 11.4.8.4. Business Strategies and Development
- 11.4.9. Ellab A/S
- 11.4.9.1. Company Overview
- 11.4.9.2. Product Portfolio
- 11.4.9.3. Financial Overview
- 11.4.9.4. Business Strategies and Development
- 11.4.10. Hycult Biotech
- 11.4.10.1. Company Overview
- 11.4.10.2. Product Portfolio
- 11.4.10.3. Financial Overview
- 11.4.10.4. Business Strategies and Development
- 11.4.11. Eurofins Biolab Srl
- 11.4.11.1. Company Overview
- 11.4.11.2. Product Portfolio
- 11.4.11.3. Financial Overview
- 11.4.11.4. Business Strategies and Development
- 11.4.12. SOLVIAS AG, Wickham Laboratories Ltd.
- 11.4.12.1. Company Overview
- 11.4.12.2. Product Portfolio
- 11.4.12.3. Financial Overview
- 11.4.12.4. Business Strategies and Development
- 12. Appendix
- 12.1. Research Methodology
- 12.2. Report Assumptions
- 12.3. Acronyms and Abbreviations
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.